参考文献:Clinical practice guideline for acute kidney injury. Section聽2: AKI definition. Kidney Inter Suppl 2: pp. 19-36 1. Vanmassenhove, J, Vanholder, R, Nagler, E, Biesen, W (2013) Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant 28: pp. 254-273 CrossRef 2. Devarajan, P (2010) Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4: pp. 265-280 CrossRef 3. Glassford, NJ, Schneider, AG, Xu, S, Eastwood, GM, Young, H, Peck, L, Venge, P, Bellomo, R (2013) The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med 39: pp. 1714-1724 CrossRef 4. Hjortrup, PB, Haase, N, Treschow, F, Moller, MH, Perner, A (2015) Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis. Acta Anaesthesiol Scand 59: pp. 25-34 CrossRef 5. Legrand, M, Jacquemod, A, Gayat, E, Collet, C, Giraudeaux, V, Launay, JM, Payen, D (2015) Failure of renal biomarkers to predict worsening renal function in high-risk patients presenting with oliguria. Intensive Care Med 41: pp. 68-76 CrossRef 6. Bihorac, A, Chawla, LS, Shaw, AD, Al-Khafaji, A, Davison, DL, Demuth, GE, Fitzgerald, R, Gong, MN, Graham, DD, Gunnerson, K, Heung, M, Jortani, S, Kleerup, E, Koyner, JL, Krell, K, Letourneau, J, Lissauer, M, Miner, J, Nguyen, HB, Ortega, LM, Self, WH, Sellman, R, Shi, J, Straseski, J, Szalados, JE, Wilber, ST, Walker, MG, Wilson, J, Wunderink, R, Zimmerman, J, Kellum, JA (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189: pp. 932-939 CrossRef 7. Kashani, K, Al-Khafaji, A, Ardiles, T, Artigas, A, Bagshaw, SM, Bell, M, Bihorac, A, Birkhahn, R, Cely, CM, Chawla, LS, Davison, DL, Feldkamp, T, Forni, LG, Gong, MN, Gunnerson, KJ, Haase, M, Hackett, J, Honore, PM, Hoste, EA, Joannes-Boyau, O, Joannidis, M, Kim, P, Koyner, JL, Laskowitz, DT, Lissauer, ME, Marx, G, McCullough, PA, Mullaney, S, Ostermann, M, Rimmele, T, Shapiro, NI, Shaw, AD, Shi, J, Sprague, AM, Vincent, JL, Vinsonneau, C, Wagner, L, Walker, MG, Wilkerson, RG, Zacharowski, K, Kellum, JA (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17: pp. R25 CrossRef 8. Ostermann M, Joannidis M (2014) Biomarkers for AKI improve clinical practice: no. Intensive Care Med (Epub Nov 12) 9. Geus, HR, Fortrie, G, Betjes, MG, Schaik, RH, Groeneveld, AB (2013) Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients. BMC Nephrol 14: pp. 273 CrossRef 10. McCullough, PA, Shaw, AD, Haase, M, Bouchard, J, Waikar, SS, Siew, ED, Murray, PT, Mehta, RL, Ronco, C (2013) Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 182: pp. 13-29 CrossRef 11. Pickering, JW, Endre, ZH (2012) New metrics for assessing diagnostic potential of candidate biomarkers. Clin J Am Soc Nephrol 7: pp. 1355-1364 CrossRef 12. Pepe, MS (2011) Problems with risk reclassification methods for evaluating prediction models. Am J Epidemiol 173: pp. 1327-1335 CrossRef 13. Prowle, JR, Liu, YL, Licari, E, Bagshaw, SM, Egi, M, Haase, M, Haase-Fielitz, A, Kellum, JA, Cruz, D, Ronco, C, Tsutsui, K, Uchino, S, Bellomo, R (2011) Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care 15: pp. R172 CrossRef 14. Waikar, SS, Betensky, RA, Emerson, SC, Bonventre, JV (2012) Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol 23: pp. 13-21 CrossRef